Faculty Profile

Arnold S. Monto, M.D.

Arnold S. Monto, M.D.

  • Professor, Epidemiology
  • Professor, Global Public Health
  • Thomas Francis, Jr. Collegiate Professor of Public Health
  • Acting Chair of the FDA's Vaccines and Related Biological Products Advisory Committee
  • 5146 SPH II
  • 1415 Washington Heights
  • Ann Arbor, Michigan 48109-2029

Dr. Monto's primary current concerns include occurrence, etiology and prevention of infectious diseases in industrialized and developing countries; frequency and cause of respiratory infections in families living in the community, and in factors which predict the occurrence and prevention of these illnesses; research and training to respond to bioterrorist threats.

  • M.D., Cornell University, 1958
  • B.A., Cornell University, 1954

  • Prevention and treatment of influenza;
    Epidemiology of respiratory infection;
    Infectious disease epidemiology.
  • Hand hygiene and mask use interventions for reducing influenza transmission in the community setting (The M-FLU Study)

  • Monto, A.S. (2003). Use of selective viral cultures to adjust nonvirologic endpoints in studies of influenza vaccine efficacy. American Journal of Epidemiology.158:312-5.
  • Monto, A.S. (2003). The role of antivirals in the control of influenza. Vaccine. 21:1796-800.
  • Monto, A.S., Pichichero, M.E., Blanckenberg, S.J., Ruuskanen, O., Cooper, C., Fleming, D.M., Kerr, C. (2002). Zanamivir prophylaxis: An effective strategy for the prevention of influenza types A and B within households. Journal of Infectious Disease. 186:1582-8.
  • Monto, A.S. (2002). Contemporary Diagnosis, Prevention, and Management of Influenza. Newton, Pennsylvania: Handbooks in Health Care Co. First Edition. pp. 1-227.
  • Welliver, R., Monto, A.S., Carewicz, O. et al. (2001). Effectiveness of oseltamivir in preventing influenza in household contacts: A randomized controlled trial. Journal of American Medical Association. 285:748-54.
  • Monto, A.S., Hornbuckle, K., Ohmit, S.E. (2001). Influenza vaccine effectiveness among elderly nursing home residents: A cohort study. American Journal of Epidemiology. 154:155-60.
  • Hayden, F.G., Gubareva, L.V., Monto, A.S., et al. (2000). Inhaled zanamivir for the prevention of influenza in families. New England Journal of Medicine. 343:1282-9.
  • Monto, A.S. (2000). Preventing influenza in healthy adults: The evolving story. Journal of American Medical Association. 284:1699-1701.
  • Monto, A.S., Gravenstein, S., Elliott, M., Colopy, M. & Schweinle, J. (2000). Clinical signs and symptoms predicting influenza infection. Archives of Internal Medicine. 160:3243-7.

  • American Association for the Advancement of Science
  • American Epidemiological Society
  • American Public Health Association
  • Infectious Diseases Society of America (Fellow)
  • Society for Epidemiologic Research
  • International Epidemiological Association

Arnold Monto in the News

Videos from our Experts

COVID-19 Vaccine

Is the End in Sight? An Inside Look at the COVID-19 Vaccine Development and Approval Process

Featuring Dr. Arnold Monto and Dr. Emily Martin. December 2, 2020

COVID-19 Vaccine

What You Should Know about the COVID-19 Vaccine

Featuring Dr. Arnold Monto and Dr. Emily Martin. January 9, 2021